Cargando…

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation

BACKGROUND: The role of DNA methylation in the regulation of the anti-donor-directed immune response after organ transplantation is unknown. Here, we studied the methylation of two mediators of the immune response: the pro-inflammatory cytokine interferon γ (IFNγ) and the inhibitory receptor program...

Descripción completa

Detalles Bibliográficos
Autores principales: Boer, Karin, de Wit, L. Elly A., Peters, Fleur S., Hesselink, Dennis A., Hofland, Leo J., Betjes, Michiel G. H., Looman, Caspar W. N., Baan, Carla C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112717/
https://www.ncbi.nlm.nih.gov/pubmed/27891189
http://dx.doi.org/10.1186/s13148-016-0288-0
_version_ 1782468058931003392
author Boer, Karin
de Wit, L. Elly A.
Peters, Fleur S.
Hesselink, Dennis A.
Hofland, Leo J.
Betjes, Michiel G. H.
Looman, Caspar W. N.
Baan, Carla C.
author_facet Boer, Karin
de Wit, L. Elly A.
Peters, Fleur S.
Hesselink, Dennis A.
Hofland, Leo J.
Betjes, Michiel G. H.
Looman, Caspar W. N.
Baan, Carla C.
author_sort Boer, Karin
collection PubMed
description BACKGROUND: The role of DNA methylation in the regulation of the anti-donor-directed immune response after organ transplantation is unknown. Here, we studied the methylation of two mediators of the immune response: the pro-inflammatory cytokine interferon γ (IFNγ) and the inhibitory receptor programmed death 1 (PD1) in naïve and memory CD8+ T cell subsets in kidney transplant recipients receiving immunosuppressive medication. Both recipients experiencing an episode of acute allograft rejection (rejectors) as well as recipients without rejection (non-rejectors) were included. RESULTS: CpGs in the promoter regions of both IFNγ and PD1 were significantly (p < 0.001) higher methylated in the naïve CD8+ T cells compared to the memory T cell subsets. The methylation status of both IFNγ and PD1 inversely correlated with the percentage of IFNγ or PD1-producing cells. Before transplantation, the methylation status of both IFNγ and PD1 was not significantly different from healthy donors. At 3 months after transplantation, irrespective of rejection and subsequent anti-rejection therapy, the IFNy methylation was significantly higher in the differentiated effector memory CD45RA+ (EMRA) CD8+ T cells (p = 0.01) whereas the PD1 methylation was significantly higher in all memory CD8+ T cell subsets (CD27+ memory; p = 0.02: CD27− memory; p = 0.02: EMRA; p = 0.002). Comparing the increase in methylation in the first 3 months after transplantation between rejectors and non-rejectors demonstrated a significantly more prominent increase in the PD1 methylation in the CD27− memory CD8+ T cells in rejectors (increase in rejectors 14%, increase in non-rejectors 1.9%, p = 0.04). The increase in DNA methylation in the other memory CD8+ T cells was not significantly different between rejectors and non-rejectors. At 12 months after transplantation, the methylation of both IFNγ and PD1 returned to baseline levels. CONCLUSIONS: The DNA methylation of both IFNγ and PD1 increases the first 3 months after transplantation in memory CD8+ T cells in kidney transplant recipients. This increase was irrespective of a rejection episode indicating that general factors of the kidney transplantation procedure, including the use of immunosuppressive medication, contribute to these variations in DNA methylation.
format Online
Article
Text
id pubmed-5112717
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51127172016-11-25 Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation Boer, Karin de Wit, L. Elly A. Peters, Fleur S. Hesselink, Dennis A. Hofland, Leo J. Betjes, Michiel G. H. Looman, Caspar W. N. Baan, Carla C. Clin Epigenetics Research BACKGROUND: The role of DNA methylation in the regulation of the anti-donor-directed immune response after organ transplantation is unknown. Here, we studied the methylation of two mediators of the immune response: the pro-inflammatory cytokine interferon γ (IFNγ) and the inhibitory receptor programmed death 1 (PD1) in naïve and memory CD8+ T cell subsets in kidney transplant recipients receiving immunosuppressive medication. Both recipients experiencing an episode of acute allograft rejection (rejectors) as well as recipients without rejection (non-rejectors) were included. RESULTS: CpGs in the promoter regions of both IFNγ and PD1 were significantly (p < 0.001) higher methylated in the naïve CD8+ T cells compared to the memory T cell subsets. The methylation status of both IFNγ and PD1 inversely correlated with the percentage of IFNγ or PD1-producing cells. Before transplantation, the methylation status of both IFNγ and PD1 was not significantly different from healthy donors. At 3 months after transplantation, irrespective of rejection and subsequent anti-rejection therapy, the IFNy methylation was significantly higher in the differentiated effector memory CD45RA+ (EMRA) CD8+ T cells (p = 0.01) whereas the PD1 methylation was significantly higher in all memory CD8+ T cell subsets (CD27+ memory; p = 0.02: CD27− memory; p = 0.02: EMRA; p = 0.002). Comparing the increase in methylation in the first 3 months after transplantation between rejectors and non-rejectors demonstrated a significantly more prominent increase in the PD1 methylation in the CD27− memory CD8+ T cells in rejectors (increase in rejectors 14%, increase in non-rejectors 1.9%, p = 0.04). The increase in DNA methylation in the other memory CD8+ T cells was not significantly different between rejectors and non-rejectors. At 12 months after transplantation, the methylation of both IFNγ and PD1 returned to baseline levels. CONCLUSIONS: The DNA methylation of both IFNγ and PD1 increases the first 3 months after transplantation in memory CD8+ T cells in kidney transplant recipients. This increase was irrespective of a rejection episode indicating that general factors of the kidney transplantation procedure, including the use of immunosuppressive medication, contribute to these variations in DNA methylation. BioMed Central 2016-11-16 /pmc/articles/PMC5112717/ /pubmed/27891189 http://dx.doi.org/10.1186/s13148-016-0288-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Boer, Karin
de Wit, L. Elly A.
Peters, Fleur S.
Hesselink, Dennis A.
Hofland, Leo J.
Betjes, Michiel G. H.
Looman, Caspar W. N.
Baan, Carla C.
Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title_full Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title_fullStr Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title_full_unstemmed Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title_short Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
title_sort variations in dna methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112717/
https://www.ncbi.nlm.nih.gov/pubmed/27891189
http://dx.doi.org/10.1186/s13148-016-0288-0
work_keys_str_mv AT boerkarin variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT dewitlellya variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT petersfleurs variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT hesselinkdennisa variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT hoflandleoj variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT betjesmichielgh variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT loomancasparwn variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation
AT baancarlac variationsindnamethylationofinterferongammaandprogrammeddeath1inallograftrejectionafterkidneytransplantation